Sex differences in patients undergoing transcatheter aortic valve replacement in Asia.


Journal

Open heart
ISSN: 2053-3624
Titre abrégé: Open Heart
Pays: England
ID NLM: 101631219

Informations de publication

Date de publication:
01 2021
Historique:
received: 01 12 2020
revised: 12 12 2020
accepted: 14 12 2020
entrez: 9 1 2021
pubmed: 10 1 2021
medline: 23 9 2021
Statut: ppublish

Résumé

Transcatheter aortic valve replacement (TAVR) is increasingly performed. Physically small Asians have smaller aortic root and peripheral vessel anatomy. The influence of gender of Asian patients undergoing TAVR is unknown and may affect outcomes. The aim of this study was to assess sex differences in Asian patients undergoing TAVR. Patients undergoing TAVR from eight countries were enrolled. In this retrospective analysis, we examined differences in characteristics, 30-day clinical outcomes and 1-year survival between female and male Asian patients. Eight hundred and seventy-three patients (54.4% women) were included. Women were older, smaller and had less coronary artery and lung disease but tended to have higher logistic EuroSCOREs. Smaller prostheses were used more often in women. Major vascular complications occurred more frequently in women (5.5% vs 1.8%, p<0.01); however, 30-day stroke and mortality (women vs men: 1.5% vs 1.6%, p=0.95% and 4.3% vs 3.4%, p=0.48) were similar. Functional status improvement was significant and comparable between the sexes. Conduction disturbance and permanent pacemaker requirements (11.2% vs 9.0%, p=0.52) were also similar as was 1-year survival (women vs men: 85.6% vs 88.2%, p=0.25). The only predictors of 30-day mortality were major vascular injury in women and age in men. Asian women had significantly smaller stature and anatomy with some differences in clinical profiles. Despite more frequent major vascular complications, women had similar 30-day stroke or mortality rates. Functional status improvement was significant and comparable between the sexes. Conduction disturbance and permanent pacemaker requirements were similar as was 1-year survival.

Identifiants

pubmed: 33419935
pii: openhrt-2020-001541
doi: 10.1136/openhrt-2020-001541
pmc: PMC7798412
pii:
doi:

Types de publication

Journal Article Multicenter Study Observational Study

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: PTLC, KH, YW, W-HY, MKYL, MC, WJK, KC, M-SL and HSK have served as proctors for Edwards Lifesciences. PTLC, YW, W-HY, H-LK, MKYL, WB, Dy, KC, M-SL, KWH and HSK have served as proctors for Medtronic. WJK has served as a consultant for Medtronic.

Références

EuroIntervention. 2013 Jul;9(3):367-72
pubmed: 23872650
Ann Thorac Surg. 2015 Mar;99(3):809-16
pubmed: 25633460
Eur Heart J. 2012 Oct;33(19):2403-18
pubmed: 23026477
J Am Coll Cardiol. 2012 Sep 4;60(10):882-6
pubmed: 22818068
J Am Coll Cardiol. 2012 Feb 7;59(6):566-71
pubmed: 22300690
N Engl J Med. 2017 Apr 6;376(14):1321-1331
pubmed: 28304219
Ann Thorac Surg. 2003 Jul;76(1):75-83
pubmed: 12842517
J Thorac Cardiovasc Surg. 2014 May;147(5):1529-39
pubmed: 23856202
Am J Cardiol. 2015 Nov 15;116(10):1566-73
pubmed: 26428022
J Am Coll Cardiol. 2015 Jul 21;66(3):221-228
pubmed: 26184614
N Engl J Med. 2010 Oct 21;363(17):1597-607
pubmed: 20961243
N Engl J Med. 2016 Apr 28;374(17):1609-20
pubmed: 27040324
Catheter Cardiovasc Interv. 2014 Aug 1;84(2):293-300
pubmed: 23873857
N Engl J Med. 2019 May 2;380(18):1695-1705
pubmed: 30883058
JACC Cardiovasc Interv. 2018 Apr 23;11(8):771-780
pubmed: 29673509
JACC Cardiovasc Interv. 2016 May 9;9(9):926-33
pubmed: 27151607
Am J Cardiol. 2014 Oct 15;114(8):1269-74
pubmed: 25159239
Catheter Cardiovasc Interv. 2018 Jun;91(7):1354-1362
pubmed: 29024382
J Am Coll Cardiol. 2016 Dec 27;68(25):2733-2744
pubmed: 28007135
Singapore Med J. 2009 May;50(5):534-7
pubmed: 19495528
J Invasive Cardiol. 2020 Aug;32(8):295-301
pubmed: 32198317
N Engl J Med. 2019 May 2;380(18):1706-1715
pubmed: 30883053
Am J Cardiol. 2014 Feb 1;113(3):522-8
pubmed: 24326271
EuroIntervention. 2018 May 20;14(1):35-37
pubmed: 29786544
Catheter Cardiovasc Interv. 2017 Feb 15;89(3):429-436
pubmed: 27468953
J Am Coll Cardiol. 2019 Dec 3;74(22):2758-2767
pubmed: 31562908
Int J Cardiol. 2013 Aug 20;167(4):1373-9
pubmed: 22521376
N Engl J Med. 2011 Jun 9;364(23):2187-98
pubmed: 21639811
Interact Cardiovasc Thorac Surg. 2018 Mar 1;26(3):420-424
pubmed: 29096029

Auteurs

Paul T L Chiam (PTL)

The Heart and Vascular Centre, Mount Elizabeth Medical Centre, Singapore paulchiam@heartvascularcentre.com.

Kentaro Hayashida (K)

Department of Cardiology, Keio University School of Medicine, Tokyo, Japan.

Yusuke Watanabe (Y)

Department of Cardiology, Teikyo University Hospital, Tokyo, Japan.

Wei-Hsian Yin (WH)

Division of Cardiology, Heart Center, Cheng-Hsin General Hospital, Taipei, Taiwan.

Hsien-Li Kao (HL)

Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.

Michael K Y Lee (MKY)

Department of Cardiology, Queen Elizabeth Hospital, Hong Kong, Hong Kong.

Fabio Enrique Posas (FE)

Department of Cardiology, St. Luke's Medical Centre, Manila, Philippines.

Mann Chandavimol (M)

Division of Cardiology, Ramathibodi Hospital, Bangkok, Thailand.

Wacin Buddhari (W)

Medicine, Chulalongkorn University, Bangkok, Thailand.

Timothy C Dy (TC)

Heart Institute, Chinese General Hospital and Medical Centre, Manila, Philippines.

Ngoc Quang Nguyen (NQ)

Department of Cardiology, Vietnam National Heart Institute, Hanoi, Vietnam.

Won Jang Kim (WJ)

Department of Cardiology, CHA Bundang Medical Centre, Seoul, Republic of Korea.

Kiyuk Chang (K)

Cardiology, The Catholic University of Korea Seoul St. Mary's Hospital, Seoul, Republic of Korea.

Mao-Shin Lin (MS)

Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.

Yat-Yin Lam (YY)

Hong Kong Asia Heart Centre, Canossa Hospital, Hong Kong, Hong Kong.

Hung Manh Pham (HM)

Department of Cardiology, Vietnam National Heart Institute, Hanoi, Vietnam.

Shaiful Azmi Yahaya (SA)

Department of Cardiology, National Heart Institute, Kuala Lumpur, Malaysia.

Kay Woon Ho (KW)

Department of Cardiology, National Heart Centre Singapore, Singapore.

Wenzhi Pan (W)

Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai, China.

Xian-Bao Liu (XB)

Department of Cardiology, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.

Jian'an Wang (J)

Cardiology, Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.

Hyo Soo Kim (HS)

Department of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea.

Mao Chen (M)

Department of Cardiology, Sichuan University West China Hospital, Chengdu, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH